The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of post-operative treatment with concurrent systemic therapy and radiotherapy (RT) in intermediate (INT) risk resected oral cavity squamous cell carcinoma (OCSCC): A multi-institutional collaboration.
 
Jessica Lyn Geiger
Research Funding - Genentech/Roche (Inst); Regeneron (Inst)
 
Neil McIver Woody
No Relationships to Disclose
 
C. Jillian Tsai
No Relationships to Disclose
 
Ahmed I. Ghanem
No Relationships to Disclose
 
Neal Dunlap
No Relationships to Disclose
 
Howard Liu
No Relationships to Disclose
 
Brian B. Burkey
No Relationships to Disclose
 
Eric Lamarre
No Relationships to Disclose
 
Jamie Ku
No Relationships to Disclose
 
Joseph Scharpf
No Relationships to Disclose
 
Nikhil Purushottam Joshi
No Relationships to Disclose
 
Jimmy J. Caudell
Consulting or Advisory Role - ProKnow
 
Farzan Siddiqui
No Relationships to Disclose
 
Sandro Porceddu
Consulting or Advisory Role - Merck Serono; Merck Sharp & Dohme; Oral Oncology; UpToDate
Travel, Accommodations, Expenses - Merck Serono; Merck Sharp & Dohme
 
Nancy Y. Lee
Stock and Other Ownership Interests - AstraZeneca (I); AstraZeneca (I)
Consulting or Advisory Role - Merck; Merck Serono; pfizer; Sanofi
Research Funding - AstraZeneca
 
Shlomo A. Koyfman
Research Funding - Merck Sharp & Dohme
Other Relationship - UpToDate; Varian Medical Systems
 
David J. Adelstein
No Relationships to Disclose